Evidently, cardiac glycosides prevent the interaction of Src with the enzyme, leading to the activation of multiple protein kinase cascades, including PI3K, Phospholipase C, and MAPK signaling, and ultimately the apoptosis of cancer cells. This evidence concerns the gene SRC and cancer.